HCA
CRNX icon

Harbor Capital Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Harbor Capital Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,150
Closed -$20.7K – 489
2023
Q2 		$20.7K Buy
+1,150
New +$20.7K ﹤0.01% 594